Your browser doesn't support javascript.
loading
Seroprevalence of hepatitis A virus infection in Central-West of Tunisia.
Ayouni, Kaouther; Kharroubi, Ghassen; Mallekh, Rym; Hammami, Walid; Marouani, Ridha; Mhamdi, Moncef; Ben Salah, Afif; Triki, Henda; Bettaieb, Jihène.
Afiliación
  • Ayouni K; Laboratory of Clinical Virology, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Kharroubi G; Clinical Investigation Center, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Mallekh R; Faculty of Sciences of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Hammami W; Clinical Investigation Center, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Marouani R; Department of Epidemiology, Clinical Investigation Center, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Mhamdi M; Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Ben Salah A; Department of Epidemiology, Clinical Investigation Center, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Triki H; Faculty of Medicine of Tunis, University of Tunis El Manar, Tunis, Tunisia.
  • Bettaieb J; Laboratory of Clinical Virology, Pasteur Institute of Tunis, University of Tunis El Manar, Tunis, Tunisia.
J Med Virol ; 93(6): 3666-3671, 2021 06.
Article en En | MEDLINE | ID: mdl-32986240
ABSTRACT
Hepatitis A infections still represent a major global health concern. During the past years, a transition pattern of the hepatitis A epidemiology was noted in many parts of the world. In Tunisia, there is not a recent survey on age-specific hepatitis A virus seroprevalence. This study aimed to investigate the seroprevalence of hepatitis A virus infection in Central-West Tunisia, representative of regions with lowest socioeconomic level in the country, before vaccine implementation. Sera obtained from the blood samples of subjects were screened for the detection of hepatitis A virus. The seroprevalence was evaluated by detection of total antibodies to hepatitis A virus using commercially available immunoassay kits. A total of 1379 subjects, aged 5-75 years (mean age 29.0 ± 17.3 years) were studied. The global anti-hepatitis A virus seroplevalence was 84.7% (95% confidence interval [82.6-86.5]). A higher hepatitis A virus seroprevalence was showed in subjects aged 10-14 years compared to those aged less than 10 years (50.0% vs. 31.0%). In subjects aged 20-29 years, a rapid increase in the hepatitis A virus prevalence was noted; it reached 97.0%. The seroprevalence of anti-hepatitis A virus differed by zone of residence (81.1% in rural area vs. 72.4% in urban area, p = .005) and increased significantly with lower level of education (p = .019). There was no statistical significant seroprevalence difference between male and female 84.2% versus 85.2%, respectively. Our study confirm the transition pattern of the hepatitis A virus endemicity in Tunisia from high to intermediate and provide an evaluation of the hepatitis A virus epidemiological situation before vaccine implementation.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis A / Hepatitis A Tipo de estudio: Etiology_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Virus de la Hepatitis A / Hepatitis A Tipo de estudio: Etiology_studies / Prevalence_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged País/Región como asunto: Africa Idioma: En Año: 2021 Tipo del documento: Article